• Heart Failure Congress 2015:
  Ivabradine is effective in chronic heart failure patients whatever the number of comorbidities
• The American College of Cardiology 2015:
  Ivabradine is effective in chronic heart failure patients with or without angina
• Heart Failure Congress 2014:
  The efficacy and safety of ivabradine are similar in diabetic and nondiabetic patients
• ESC Congress 2013:
  Ivabradine’s clinical benefits in CHF are maintained with or without renal dysfunction
  The benefits and tolerability of ivabradine are similar irrespective of blood pressure
  SHIFT is the basis of a prognostic model for heart failure patients
  Ivabradine’s efficacy and safety are maintained with or without COPD